Europeans Ditch Cars Amid Recession, GM (GM) Stock Rocked
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
Tweet
Share
E-mail
Get Alerts GM Hot Sheet
Price: $82.01 +2.22%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.9%
EPS Growth %: +30.7%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.9%
EPS Growth %: +30.7%
Join SI Premium – FREE
European car registrations fell 16 percent in December, sending shares of U.S. automakers GM (NYSE: GM) and Ford (NYSE: F) lower. Shares of GM opened lower by 4 percent, and Ford stock dropped. 0.8 percent.
The massive drop in Europe car sales comes amid recession in the region, resulting in the worst year for auto sales in 19 years, with sales declining 7.8 percent.
Pain in European autos is nothing new, and carmakers have been cutting jobs and reorganizing operations for months. For example, Ford last year announced it was closing plants in the region. However, the extent of December's drop in autos was larger than expected and stunned many watching.
The massive drop in Europe car sales comes amid recession in the region, resulting in the worst year for auto sales in 19 years, with sales declining 7.8 percent.
Pain in European autos is nothing new, and carmakers have been cutting jobs and reorganizing operations for months. For example, Ford last year announced it was closing plants in the region. However, the extent of December's drop in autos was larger than expected and stunned many watching.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Caribou Biosciences to halt CAR-T programs, explore sale
- Halozyme expands argenx deal to cover two more drug targets
- Chevron to sell Hess Midstream stake in deal cutting Bakken costs
Create E-mail Alert Related Categories
Corporate News, Insiders' BlogRelated Entities
LayoffsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
